Skip to main content

Table 1 Clinical material

From: Effects of MCF2L2, ADIPOQ and SOX2 genetic polymorphisms on the development of nephropathy in type 1 Diabetes Mellitus

  T1DM without DN T1DM with DN
  All Female Male All Female Male
N 599 357 242 578 265 313
Age (years) 40 ± 8 40 ± 9 40 ± 8 44 ± 6 44 ± 7 45 ± 6
Duration of diabetes (years) 26 ± 8 26 ± 8 26 ± 8 32 ± 8 32 ± 8 32 ± 8
HbA1c (%) 7.5 ± 1.1 7.5 ± 1.1 7.4 ± 1.1 7.4 ± 1.9 7.4 ± 2.1 7.4 ± 1.7
BMI (kg/m2) 26.0 ± 4.4 25.7 ± 4.7 26.6 ± 3.7 25.7 ± 5.3 25.2 ± 5.7 26.2 ± 4.8
Creatinine (mg/dL) 0.9 ± 0.2 0.8 ± 0.1 1.0 ± 0.1 2.1 ± 1.9 1.9 ± 1.6 2.3 ± 2.0
Cystatin (mg/L) 0.8 ± 0.1 0.8 ± 0.1 0.8 ± 0.1 2.2 ± 1.7 2.2 ± 1.6 2.4 ± 1.7
Cholesterol (mg/dL) 185.0 ± 31.3 188.7 ± 30.9 179.7 ± 31.2 186.3 ± 45.9 190.3 ± 47.3 183.1 ± 44.5
HDL (mg/dL) 59.1 ± 15.9 64.8 ± 15.5 51.0 ± 12.4 53.6 ± 17.3 59.3 ± 18.2 48.9 ± 15.0
Systolic BP (mm Hg) 118 ± 12 116 ± 12 122 ± 12 131 ± 19 130 ± 20 133 ± 18
Diastolic BP (mm Hg) 71 ± 8 70 ± 7 74 ± 8 74 ± 11 72 ± 11 75 ± 11
  1. All data are means ± SD. T1DM = Type 1 diabetic patients, DN = diabetic nephropathy.